Abl inhibitor BMS354825 binding mode in Abelson kinase revealed by molecular docking studies
Published inLeukemia, vol. 19, no. 7, p. 1267-1269
Publication date2005-07
Keywords
- Computer Simulation
- Dasatinib
- Models, Molecular
- Protein Binding / drug effects
- Protein Conformation
- Protein Kinase Inhibitors / chemistry
- Protein Kinase Inhibitors / pharmacology
- Protein Structure, Tertiary
- Protein-Tyrosine Kinases / antagonists & inhibitors
- Protein-Tyrosine Kinases / chemistry
- Proto-Oncogene Proteins c-abl / antagonists & inhibitors
- Proto-Oncogene Proteins c-abl / chemistry
- Pyrimidines / chemistry
- Pyrimidines / pharmacology
- Structure-Activity Relationship
- Thiazoles / chemistry
- Thiazoles / pharmacology
Affiliation entities
Citation (ISO format)
GAMBACORTI-PASSERINI, Carlo et al. Abl inhibitor BMS354825 binding mode in Abelson kinase revealed by molecular docking studies. In: Leukemia, 2005, vol. 19, n° 7, p. 1267–1269. doi: 10.1038/sj.leu.2403775
Main files (1)
Article (Published version)
Identifiers
- PID : unige:166171
- DOI : 10.1038/sj.leu.2403775
- PMID : 15858616
Journal ISSN0887-6924
